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Abstract: Body shape index (ABSI) and triponderal mass index (TMI) have been recently associated
with cardiovascular risk in adults. A cross-sectional study was conducted to evaluate the relationship
between different anthropometric adiposity indexes and metabolic syndrome (MetS) in Caucasian
obese children and adolescents. Consecutive obese children aged ≥7 years have been enrolled.
Anthropometric parameters, body composition (by bioelectrical impedance), and systolic and
diastolic blood pressure have been measured. Fasting blood samples have been analyzed for lipids,
insulin, glucose. A multivariate logistic regression analyses, with body mass index z-score, waist to
height ratio, ABSI z-score, TMI, conicity index as predictors for MetS (IDEFICS and IDF criteria
according to age) has been performed. Four hundred and three (179 boys and 224 girls) obese
children, aged 7–20 years, have been evaluated. When we explored the joint contribution of each
anthropometric and adiposity index of interest and BMIz on the risk of MetS, we found that the
inclusion of ABSIz improved the prediction of MetS compared to BMIz alone. ABSI-BMI can be
a useful index for evaluating the relative contribution of central obesity to cardiometabolic risk in
clinical management of obese children and adolescents.
Keywords: adiposity indices; metabolic syndrome; childhood obesity
1. Introduction
Childhood obesity is considered one of the most serious global public health challenges in the
21st century [1] in terms of prevalence and economic burden [2,3]. According to WHO data, 41 million
children under the age of 5 years and 340 million children and adolescents aged 5–19 years are
overweight or obese worldwide [4]. The latest WHO European Childhood Obesity Surveillance
Initiative (COSI) data collection showed an increase in obesity prevalence in school-aged children
(6–9 years) now affecting 21% of boys and 19% of girls [5].
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Obesity may be associated with adverse health effects during childhood and with an increased
risk of metabolic and cardiovascular morbidity and mortality later in life. Moreover, obese children
can develop dyslipidemia, hypertension, and disorders of glucose metabolism, hallmarks of metabolic
syndrome (MetS), more frequently during adolescence [6,7]. These long-term effects, especially if
obesity status develops early in life, seem to be related to imbalanced gut microbiome, inflammation,
impaired insulin signaling, and metabolic dysregulation [8]. Intensive lifestyle modifications, involving
diet, physical activity, and behavioral changes are the key points of the actual guidelines to prevent
and manage childhood obesity [9–12]. A reference method for the assessment of body composition is
dual-energy X-ray absorptiometry (DXA). However, DXA, as well as air displacement plethysmography,
is not widely available (partly because of the associated costs) as anthropometry, a simple, noninvasive,
and inexpensive technique.
Body mass index (BMI) is the most used indicator in epidemiological studies and clinical setting
and it is used as surrogate for the evaluation of body composition [13] but is not able to distinguish fat
from lean mass, nor it is indicative of the adipose tissue distribution [14].
In children, the use of age- and gender-adjusted BMI z-score has been recommended instead of
BMI; however, the association of childhood BMI z-score with cardiometabolic risk is nonlinear [15].
Different adiposity indexes have been evaluated to identify those with the best predictiveness
for MetS. Waist circumference (WC) has been investigated in evaluation of body composition and
cardiometabolic risk, as WC reflects also fat distribution and fat percentage [16]. WC has been shown to
be a better predictor of hypertension and impaired glucose metabolism in adolescents when compared
to BMI [17,18]. Perona suggested that WC is one of the strongest anthropometric discriminator of MetS
among Spanish adolescents [19].
Waist to height ratio (WHtR) has been raised as a good marker of MetS in childhood [20]
and it could have greater practical advantages over BMI and WC alone [21]. Joyce has suggested
WHtR as a useful screening measure to identify adolescents at higher risk of hypertension in routine
primary-level health services [22]. Nevertheless, some studies were not able to demonstrate a significant
difference in the predictive abilities of BMI, WC, WHtR [23–25]. Recently, a new index, the body
shape index (ABSI), related to the abdominal to peripheral fat ratio, has been specifically developed
to stress the importance of waist circumference in abdominal obesity, associated with metabolic and
cardiovascular alterations [26,27]. Since the ABSI is calculated using both waist circumference and BMI,
it is possible that it may be a better predictor of BMI in assessing disease risk [27]. In adults, ABSI is a
well-demonstrated predictor of total mortality and of incident cardiovascular disease (CVD) [28] with
an accuracy similar to that of common laboratory measurements [29]. Concerning cardio-metabolic risk
factor, we recently demonstrated that it is a useful index for evaluating the independent contribution
of WC, in addition to that of BMI, as a surrogate for central obesity by ultrasonography [26]. Indeed,
ABSI has been shown to be significantly associated with cardiometabolic risk markers in a pediatric
overweight or obese population [30]. Also triponderal mass index (TMI) has been recently suggested
as useful tools in the evaluation of body composition [31] and have been studied as predictors of
MetS [32] in children and adolescents. It is still controversial whether conicity index (C-Index) could
be useful to screen for MetS [33].
The aim of this study is to evaluate the relationship between different anthropometric adiposity
indexes (AAIs) and metabolic syndrome (MetS) and to identify which of the AAIs allows a better
assessment of the probability of having MetS in Caucasian obese children and adolescents aged
≥7 years.
2. Results
Table 1 shows the anthropometric measurements, the adiposity indexes and the biochemical
parameters of the recruited children and adolescents.
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Table 1. Characteristics of the recruited subjects according to age class.
7–9.9 Years
n = 84
10–15.9 Years
n = 229
16–19.9 Years
n = 90
Total
n = 403
P25 P50 P75 P25 P50 P75 P25 P50 P75 P25 P50 P75
Age (years) 8 9 9 12 13 14 17 17 19 10 13 16
Weight (kg) 43.0 48.5 53.8 63.5 74.0 85.3 87.3 93.5 104.4 56.6 74.8 90.3
Weight z-score 1.900 2.244 2.499 1.827 2.077 2.392 1.770 2.037 2.294 1.827 2.089 2.403
Height (cm) 133.1 139.3 143.6 151.2 157.4 165.4 163.3 169.9 175.7 145.5 156.7 167.5
Height z-score 0.240 0.948 1.803 −0.158 0.460 1.088 −0.414 0.051 0.546 −0.117 0.457 1.169
BMI (kg/m2) 23.7 24.8 27.1 27.0 29.1 31.4 30.5 32.6 36.1 26.6 29.4 32.3
BMI z-score 1.998 2.129 2.315 1.891 2.030 2.227 1.768 1.985 2.182 1.877 2.055 2.255
WC (cm) 78.0 81.5 86.2 86.0 92.5 98.8 96.6 101.8 109.4 84.8 92.0 100.7
ABSI 0.078 0.081 0.084 0.074 0.078 0.081 0.073 0.077 0.079 0.075 0.078 0.081
ABSI z-score −0.029 0.705 1.214 −0.544 0.116 0.798 −0.395 0.389 0.849 −0.401 0.255 0.949
Total mass index 16.9 17.9 19.4 17.2 18.1 19.8 17.7 19.1 21.4 17.2 18.3 20.1
C-index 1.2 1.3 1.3 1.2 1.3 1.3 1.2 1.3 1.3 1.2 1.3 1.3
WHtR 0.56 0.59 0.62 0.55 0.58 0.62 0.56 0.60 0.65 0.56 0.59 0.62
Glucose (mg/dL) 79 83 89 82 88 93 84 90 96 81 87 93
Insulin 8.5 11.9 15.4 12.0 16.7 23.3 13.0 18.2 23.8 11.4 15.8 22.6
HOMA index 1.7 2.3 3.4 2.5 3.6 5.2 2.9 4.3 5.6 2.4 3.5 5.1
HDL (mg/dL) 41 48 54 39 47 55 42 49 54 40 47 55
TG (mg/dL) 61 79 109 64 84 121 58 85 117 61 83 119
SBP (mm Hg) 103 107 114 110 116 120 115 120 130 109 116 120
DBP (mm Hg) 56 60 66 60 65 70 70 70 80 60 66 71
Abbreviations: P25 = 25th percentile; P50 = 50th percentile; P75 = 75th percentile; WC = waist circumference;
TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure.
Table 2 shows the distribution of MetS and its components in the total sample and according to
the age class. Overall, MetS was detected in 19.9% of subjects.
Table 3 shows the regression coefficients, pseudo-R2 and AIC values for the logistic regression
models used to investigate the association of the anthropometric and adiposity indices of interest
(BMIz, ABSIz, TMI, C-Index, and WHtR) with the risk of MetS according to the age group.
In children aged < 10 years, we found that only BMIz was associated with the risk of MetS.
In older children and in adolescents, all anthropometric and adiposity indices of interest, except
ABSIz, were associated with MetS risk. In this age group, BMIz and WHtR had the lowest AIC value,
suggesting an equal ability to predict MetS.
When we stratified the analysis for sex, we found C-Index and WHtR both associated with the
MetS risk in female aged ≥10 years, with C-Index having a slightly better ability to predict MetS
compared to WHtR (AIC = 127 vs. 128). In males aged ≥10 years, all anthropometric and adiposity
indices, with the only exception for ABSIz, were associated with the risk of MetS, and BMIz had the
best predictive ability (AIC = 107).
We also explored the association of anthropometric and adiposity indices with individual
components of MetS (Supplementary Table S1). In children aged < 10 years, BMIz was associated with
higher risk of high blood pressure. BMIz was also the best predictor of high blood pressure and low
HDL in females and males aged ≥ 10 years, respectively. In females aged ≥ 10 years, C-Index was the
best predictor of high triglycerides. In males ≥ 10 years, TMI better predicted high blood pressure,
while WHtR better predicted high triglycerides.
When we explored the joint contribution of each anthropometric and adiposity index of interest
and BMIz on the risk of metabolic syndrome, we found that the inclusion of ABSIz improved the
prediction of MetS compared to BMIz alone in children aged ≥ 10 years (Table 4). Because of evident
collinearity problems, we could not investigate the joint contribution of other indices and BMI in the
prediction of MetS.
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Table 2. Distribution of metabolic syndrome and its components according to age class.
7–10 Years 10–16 Years 16–20 Years Total
N % N % N % N %
Sex
Female 55 65.5 122 53.3 47 52.2 224 55.6
Male 29 34.5 107 46.7 43 47.8 179 44.4
Total 84 100 229 100 90 100 403 100
High waist circumference
No 0 0 47 20.5 6 6.7 53 13.2
Yes 84 100 182 79.5 84 93.3 350 86.8
Total 84 100 229 100 90 100 403 100
High glucose
No 80 95.2 213 93 77 85.6 370 91.8
Yes 4 4.8 16 7 13 14.4 33 8.2
Total 84 100 229 100 90 100 403 100
High HOMA index
No 35 41.7
Yes 49 58.3
Total 84 100
High glucose or High HOMA
No 35 41.7
Yes 49 58.3
Total 84 100
High triglycerides
No 53 63.1 198 86.5 76 84.4 327 81.1
Yes 31 36.9 31 13.5 14 15.6 76 18.9
Total 84 100 229 100 90 100 403 100
Low HDL
No 66 78.6 170 74.2 59 65.6 295 73.2
Yes 18 21.4 59 25.8 31 34.4 108 26.8
Total 84 100 229 100 90 100 403 100
High triglycerides or Low HDL
No 48 57.1
Yes 36 42.9
Total 84 100
High systolic blood pressure
No 65 77.4 203 88.6 62 68.9 330 81.9
Yes 19 22.6 26 11.4 28 31.1 73 18.1
Total 84 100 229 100 90 100 403 100
High diastolic blood pressure
No 77 91.7 225 98.3 80 88.9 382 94.8
Yes 7 8.3 4 1.7 10 11.1 21 5.2
Total 84 100 229 100 90 100 403 100
Metabolic syndrome
No 47 56 203 88.6 73 81.1 323 80.1
Yes 37 44 26 11.4 17 18.9 80 19.9
Total 84 100 229 100 90 100 403 100
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Table 3. Association of anthropometric indexes with the risk of metabolic syndrome according to the age group.
Children < 10 Years Children ≥ 10 Years
BMIz ABSIz TMI C-Index WHR BMIz ABSIz TMI C-Index WHR
Sex (Male) −0.51 −0.17 −0.32 −0.20 −0.28 −0.11 −0.02 0.52 −0.21 0.23
[−1.55, 0.52] [−1.11, 0.77] [−1.29, 0.65] [−1.14, 0.75] [−1.24, 0.67] [−0.77, 0.55] [−0.72, 0.68] [−0.21, 1.26] [−0.89, 0.48] [−0.45, 0.92]
Age (years) 0.44 0.30 0.30 0.27 0.26 0.18 * 0.15 * 0.11 0.15 * 0.12
[−0.16, 1.05] [−0.36, 0.95] [−0.30, 0.90] [−0.39, 0.94] [−0.37, 0.89] [0.04, 0.31] [0.02, 0.27] [−0.01, 0.24] [0.03, 0.28] [−0.01, 0.25]
BMI z-score (CDC) 2.21 * 2.67 ***
[0.31, 4.12] [1.44, 3.90]
ABSI z-score −0.10 0.37
[−0.58, 0.38] [−0.01, 0.75]
Total mass index 0.19 0.19 **
[−0.07, 0.46] [0.07, 0.32]
C-index 1.23 9.02 ***
[−5.61, 8.06] [3.79, 14.25]
Waist-to-Height ratio 5.39 12.32 ***
[−4.64, 15.41] [6.63, 18.01]
Constant −8.82 * −2.77 −6.37 −4.19 −5.68 −10.00 *** −4.10 *** −7.57 *** −15.40 *** −11.17 ***
[−16.23, −1.41] [−8.63, 3.08] [−13.61, 0.87] [−14.06, 5.67] [−13.34, 1.98] [−13.52, −6.47] [−6.06, −2.14] [−10.76, −4.37] [−22.06, −8.74] [−15.02, −7.31]
Observations 84 84 84 84 84 319 319 319 319 319
Pseudo R2 0.051 0.009 0.027 0.009 0.018 0.094 0.040 0.060 0.072 0.091
AIC 117 122 120 122 121 237 250 245 242 237
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Table 3. Cont.
Female ≥ 10 Years Male ≥ 10 Years
BMIz ABSIz TMI C-Index WHR BMIz ABSIz TMI C-Index WHR
Age (years) 0.13 0.11 0.07 0.11 0.06 0.20 * 0.19 * 0.22 * 0.21 * 0.21 *
[−0.07, 0.32] [−0.07, 0.29] [−0.12, 0.26] [−0.07, 0.29] [−0.13, 0.25] [0.01, 0.39] [0.02, 0.37] [0.04, 0.40] [0.02, 0.39] [0.03, 0.40]
BMI z-score (CDC) 1.24 3.84 ***
[−0.62, 3.10] [1.99, 5.69]
ABSI z-score 0.43 0.28
[−0.09, 0.95] [−0.23, 0.79]
Total mass index 0.09 0.35 ***
[−0.08, 0.26] [0.17, 0.53]
C-index 7.37 * 11.52 **
[0.70, 14.05] [3.09, 19.96]
Waist-to-Height ratio 7.94 * 18.79 ***
[0.78, 15.10] [9.87, 27.72]
Constant −6.29 * −3.61 ** −4.74 * −12.67 ** −7.62 *** −13.09 *** −4.71 *** −11.66 *** −19.63 *** −16.40 ***
[−11.79, −0.78] [−6.24, −0.97] [−8.58, −0.89] [−20.74, −4.61] [−11.93, −3.31] [−17.70, −8.48] [−7.44, −1.98] [−16.42, −6.90] [−31.31, −7.96] [−22.78, −10.02]
Observations 169 169 169 169 169 150 150 150 150 150
Pseudo R2 0.023 0.035 0.018 0.050 0.040 0.193 0.048 0.148 0.101 0.177
AIC 130 128 131 127 128 107 125 113 118 109
Values are regression coefficients and 95% confidence intervals [in brackets] obtained from logistic regression models adjusted for sex and age. Abbreviations: * p < 0.05 ** p < 0.01
*** p < 0.001.
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Table 4. Joint contribution of body mass index (BMI) and body shape index (ABSI) in the prediction of
metabolic syndrome.
Children < 10 Years Children ≥ 10 Years
Sex (Male) −0.51 −0.38
[−1.54, 0.52] [−1.10, 0.34]
Age (years) 0.45 0.17 *
[−0.16, 1.07] [0.04, 0.31]
BMI z-score (CDC) 2.20 * 2.79 **
[0.29, 4.12] [1.56, 4.03]
ABSI z-score −0.07 0.45 *
[−0.57, 0.43] [0.03, 0.86]
Constant −8.82 * −10.22 **
[−16.29, −1.35] [−13.58, −6.86]
Observations 84 319
Pseudo R2 0.051 0.115
AIC 119 233
Values are regression coefficients and 95% confidence intervals [in brackets] obtained from logistic regression models
adjusted for sex and age. Abbreviations: * p < 0.05 ** p < 0.001.
3. Discussion
In the present study, we tested for the first time the relationship between different anthropometric
and adiposity indexes and metabolic syndrome (MetS) risk in a large sample of Caucasian obese
children and adolescents taking into account the effects of sex and age.
We found that BMIz was independently associated and was associated with a better estimate of
the probability of having MetS, compared to other indices. Moreover, the joint use of BMIz and ABSIz
was associated with a better estimate of the probability of having MetS as compared to BMIz or ABSIz
alone and to other indices. These findings did not change when we restricted the analysis to children
aged over 10 years. Interestingly, when we stratified the analysis for sex, in subjects aged ≥10 years,
we found that only C-Index and WHtR were both associated with the MetS risk in female, whereas in
males all anthropometric and adiposity indices, with the only exception for ABSIz, were associated
with the risk of MetS and BMIz suggesting that a gender difference in waist circumference effect on
MetS is relevant.
Our results are interesting considering that ABSI, which express the WC relative to height and
weight, has been recently proposed as a new method to better evaluate the cardiometabolic risk
compared to BMI alone, both in children and in adults [26,30,31]. In a similar work, but conducted
just among adolescents, WC and abdominal volume index have been the strongest anthropometric
discriminator of MetS [19]. It has to be noted that in Perona study [19] the prevalence of MetS was 7%
and 6.1% for 13.2 (1.2) years boys and girls, respectively, using IDF criteria. In our study, the prevalence
of MetS was 11.4% considering 10–16 years old participants, then about two times greater than the
Spanish study [19], probably because of higher mean value of BMI of participants in our study.
MetS is a complex disorder defined by a cluster of nutritional and biochemical factors that directly
increase the risk of cardiovascular diseases and type 2 diabetes and its increasing prevalence in both
childhood and young adulthood has future implications to the global health burden. Our results on
the association of anthropometric and adiposity indices highlighted their different role as predictor of
risk for individual components of MetS according to sex and age. The age of obesity onset could reflect
a different cardiometabolic risk. Indeed, it was reported that patients who were obese at age ≥ 20 years
had significantly higher odds of having T2D than those with the onset of obesity before 20 years [34].
Indeed it should be noted that patients with a younger age at obesity onset are less likely to clinically
manifest consequences of obesity, such as diabetes or hypertension, compared to patients with adult
onset of obesity [35].
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However, another recent study conducted in a cohort of young women, aged 18–23 years,
underlined the importance of timing of obesity in the development of T2D, suggesting that preventing
the onset of obesity may substantially reduce the risk of developing diabetes [36]. Pacheco et al. have
noticed in a cohort of 673 Chilean patients assessed both at 5 years and in adolescent age, that, in a
multivariable model, an early onset of obesity independently contributed to a higher MetS risk score
in adolescence [37].
Unfortunately, there is still no universally accepted and clearly defined diagnostic criteria for MetS,
especially in childhood. Indeed, diagnostic criteria are different in children, adolescents, and young
adulthood, and there is no way to use unified criteria, at present. Nonetheless, in agreement with the
previous by Kassi et al. [38] in adults, our results even more stringently underscore the need for clear
MetS criteria in childhood, because of the existing controversies in this field and the need to expand
knowledge on the childhood aspect of the MetS.
Several studies demonstrated that visceral abdominal fat tissue (VAT) plays a central role in
the pathogenesis of MetS both in adults and in children [39]. Computed tomography (CT) and
magnetic resonance imaging (MRI) are the reference methods for the assessment of VAT but they cannot
be used in routine clinical practice and epidemiological research. However, ultrasonography and
bioelectrical impedance analysis has been a validated, cheap, and noninvasive alternative to reference
methods [9,40]. ABSI is positively correlated with visceral adiposity and has been also shown to be
positively associated with visceral fat thickness and area estimated respectively by ultrasonography
and bioelectrical impedance analysis [41,42]. VAT by CT and MRI correlation with ABSI has never
been investigated.
The role of abdominal adiposity as risk factor for cardiovascular and metabolic obesity-related
alterations has been extensively studied in adult population, but in children has not yet been fully
elucidated [43]. Visceral obesity may partly be a marker of a dysmetabolic state and partly a cause of
the metabolic syndrome. A recent systematic review showed that abdominal fat deposition in children
and adolescents increase the risk of cardio-metabolic alterations [44]. However, controversies exist on
the definition of abdominal obesity in the pediatric age group. BMI itself cannot differentiate between
fat and fat-free mass and does not always relate to central obesity. In addition, the recent increase in
mean BMI of children and adolescents has been accompanied by an even steeper increase in WC [44].
Although WC is a better marker of abdominal fat accumulation than the BMI, an elevated waistline
alone is not sufficient to diagnose visceral obesity and therefore the MetS risk. Indeed by using WC
alone for distinguishing between subcutaneous and visceral fat mass is not possible [45]. It is for this
reason that new adiposity indexes have been recently studied, among these ABSI, that normalizing the
WC to height and weight could be better related to the abdominal to peripheral fat ratio.
The present study has some strengths and limitations. Among the strengths, we would like to
highlight the large sample size with a large range of age of both sex, which contributes to obtaining
robust results that will be useful in future comparable studies. Additionally, the studied sample can be
considered a homogeneous sample as participating children and adolescents belonged to the same
geographical region, with supposed similar culture, lifestyle, and eating habits.
Among the limitations of the study, we must include a self-selected sample of Caucasian children
and adolescent. Our findings are not necessarily applicable to general populations and to other ethnic
groups Therefore, more studies are needed to determine whether the results obtained are consistent
using large sample of same age children.
Moreover, it is to be noted that while for BMI z-score and WHtR there are cut-off values associated
with adiposity [46,47] and cardiometabolic risk [48], they do not exist for the other adiposity indexes
analyzed in the study. A higher ABSI may correspond to a larger fraction of visceral fat [27] and since
the ABSI is calculated using both waist circumference and BMI, it is possible that it may be a better
predictor of BMI in assessing disease risk [27] but from the analysis of our data, in consideration of the
sample size, it was not possible to identify specific cut-off for ABSI to define the obesity, central obesity,
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and consequently the cardiometabolic risk in these patients. Further studies are needed to evaluate
this specific topic, including also the evaluation of VAT.
In conclusion, the joint use of ABSI and BMI allows a better assessment of the probability of METs
compared to BMI alone and to the other AAIs tested. ABSI-BMI can be a useful index, as opposed to
WC, for evaluating the relative contribution of central obesity to cardiometabolic risk in the clinical
management of obese children and adolescents. Further studies aiming to evaluate the capability of
ABSI-BMI to jointly predict longitudinal outcomes in pediatric population are warranted.
4. Materials and Methods
4.1. Study Population
We carried out a cross-sectional study on 403 Caucasian obese children and adolescents recruited
at International Center for the Assessment of Nutritional Status (ICANS), University of Milan (59.6%)
and San Paolo Hospital (40.4%), Department of Health Sciences, University of Milan, between January
2009 and June 2018. Inclusion criteria of the study were: (1) age from 7 to 20 years; (2) BMI > 95th
percentile, according to CDC [46]. Exclusion criteria: we excluded children and adolescents affected
by genetic/syndromic obesity, use of antihypertensive, antidiabetic, or lipid-lowering medication or
medications known to cause lipodystrophy such as steroids that also affect body composition. On
the same morning, the subjects underwent a medical interview, an anthropometric assessment (BMI,
ABSI, WHtR, C-Index, and TMI), a measurement of systolic (SBP) and diastolic blood pressure (DPB),
and blood sampling. The study was performed in accordance with the Declaration of Helsinki and the
subjects gave their written informed consent. The study procedures were approved by the Ethical
Committee of Milan University (report n. 23/2016).
4.2. Anthropometric Measurements
Weight and height were measured using a medical-certified scale and children’s medical-certified
stadiometer, respectively following international guidelines [49]. BMI was calculated as [50]:
BMI =
Weight(kg)
Height(m)2
BMI values were transformed into BMI z scores using CDC reference values [46]. Obesity was
defined by BMI z score ≥ 1.645. WC was measured at the midpoint between the last rib and the iliac
crest at the end of normal expiration, using an inextensible anthropometric tape positioned parallel to
the floor [49].
4.3. Adiposity Index
ABSI was calculated using the following formula [51]:
ABSI =
WC(m)
BMI2/3 ×Height(m)1/2
ABSI values were transformed into ABSI z-score using NHANES values as reference [52].
WHtR was calculated as:
WHtR =
WC(m)
Height(m)
C-Index was calculated using the following formula [53]:
C− Index = 0.109−1 ×WC×
(
Weight(kg)
Height(m)
)−1/2
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Finally, TMI was calculated using the following formula [31]:
TMI =
Weight(kg)
Height(m)3
4.4. Clinical Assessment
A structured medical interview was carried out in order to obtain information about clinical
history of the subject and possible drug therapies followed. Resting blood pressure (BP) was measured
twice in sitting position after participants had rested for at least five minutes [54].
4.5. Laboratory Assessment
A blood sample was obtained in fasting state between 8:30 a.m. and 9:00 a.m. for measurement
of plasma glucose, insulin, triglycerides (TG), HDL-cholesterol and analyzed in the same morning
at the internal laboratory. The homeostasis model assessment of insulin resistance (HOMA-IR) was
calculated using the following formula [55]:
HOMA−R =
Glucose
(
mmol
L
)
× Insulin
(
mU
L
)
22.5
4.6. Metabolic Syndrome
Different criteria have been used for the diagnosis of metabolic syndrome (MetS) according to
age groups.
For children aged from 7 to 10 years, metabolic syndrome was defined as reported by
Ahrens et al. [56] in the IDEFICS study, with at least three of the following criteria: WC ≥ 90th
percentile [57]; systolic or diastolic pressure ≥ 90th percentile [58]; triglycerides ≥ 90th percentile or
HDL ≤ 10th percentile [59]; HOMA-IR ≥ 90th percentile or fasting blood sugar ≥ 90th percentile [60].
For children aged from 10 to 16 years, MetS was defined as proposed by IDF consensus [6],
with WC ≥ 90th percentile for age and sex [61] plus at least 2 of the following criteria: fasting blood
glucose ≥ 100 mg/dL (≥5–6 mmol/L); triglycerides ≥ 150 mg/dL (≥1.7 mmol/L); HDL < 40 mg/dL;
SBP ≥ 130 mmHg or DBP ≥ 85 mmHg.
For patients age ≥ 16 years, MetS was defined following IDF criteria [62], with WC ≥ 94 cm
for males and ≥80 cm for females, plus two of the following factors: fasting glucose > 100 mg/dL,
TG ≥ 150 mg/dL, HDL-cholesterol < 40 mg/dL in males and <50 mg/dL in females, SBP ≥ 135 mmHg
or DBP ≥ 85 mmHg.
4.7. Statistical Analysis
Several continuous variables did not follow a normal distribution and are therefore reported as
25th, 50th, and 75th percentile. Discrete variables are reported as frequency and percentage. Logistic
regression models adjusted for sex and age were used to investigate the association between the
anthropometric indices of interest (BMIz, ABSIz, TMI, C-Index, and WHtR) and the risk of MetS.
We also investigated the joint contribution of each of the indices of interest and BMIz on the risk of MetS.
However, because of evident collinearity problems, we could only investigate the joint contribution of
BMIz and ABSIz. Multivariable fractional polynomials were used to ensure the linearity of continuous
predictors with the outcomes. We used the Hosmer-Lemeshow test to assess the goodness of fit of the
models. We reported McFadden pseudo-R2 as measures of predictive ability. To develop a relative
comparison of the models we used the Akaike information criterion (AIC). The choice of the best
predictive model was made on the basis of the lowest AIC value. Statistical analysis was performed
using STATA version 12.0 (StataCorp, College Station, TX, USA).
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